Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1986 29
1987 49
1988 69
1989 89
1990 133
1991 116
1992 139
1993 172
1994 207
1995 175
1996 168
1997 195
1998 232
1999 251
2000 293
2001 264
2002 313
2003 329
2004 376
2005 556
2006 685
2007 755
2008 743
2009 952
2010 1168
2011 1322
2012 1458
2013 1734
2014 1667
2015 1797
2016 1837
2017 1781
2018 1687
2019 878
2020 46
Text availability
Article attribute
Article type
Publication date

Search Results

20,377 results
Results by year
Filters applied: . Clear all
Page 1
Liquid biopsies come of age: towards implementation of circulating tumour DNA.
Wan JCM, Massie C, Garcia-Corbacho J, Mouliere F, Brenton JD, Caldas C, Pacey S, Baird R, Rosenfeld N. Wan JCM, et al. Nat Rev Cancer. 2017 Apr;17(4):223-238. doi: 10.1038/nrc.2017.7. Epub 2017 Feb 24. Nat Rev Cancer. 2017. PMID: 28233803 Review.
EGFR T790M and C797S Mutations as Mechanisms of Acquired Resistance to Dacomitinib.
Kobayashi Y, Fujino T, Nishino M, Koga T, Chiba M, Sesumi Y, Ohara S, Shimoji M, Tomizawa K, Takemoto T, Mitsudomi T. Kobayashi Y, et al. J Thorac Oncol. 2018 May;13(5):727-731. doi: 10.1016/j.jtho.2018.01.009. Epub 2018 Feb 2. J Thorac Oncol. 2018. PMID: 29410323 Free article.
Poziotinib for uncommon ERBB mutations.
Romero D. Romero D. Nat Rev Clin Oncol. 2018 Jul;15(7):404. doi: 10.1038/s41571-018-0038-7. Nat Rev Clin Oncol. 2018. PMID: 29743681 No abstract available.
Osimertinib in EGFR Mutation-Positive Advanced NSCLC.
Soria JC, Ramalingam SS. Soria JC, et al. N Engl J Med. 2018 Mar 29;378(13):1262-1263. doi: 10.1056/NEJMc1801669. N Engl J Med. 2018. PMID: 29590540 No abstract available.
20,377 results
Jump to page
Feedback